{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:43:29Z","timestamp":1786167809884,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-026-02047-6","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:40:25Z","timestamp":1782452425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor Expression of Cerebellar Degeneration-Related Protein 2-Like in Rapidly Progressive Cerebellar Syndrome Associated With Oropharyngeal Squamous Cell Carcinoma"],"prefix":"10.1007","volume":"25","author":[{"given":"Keishu","family":"Murakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Yorozu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Tamagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneki","family":"Hotomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuichi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"2047_CR1","doi-asserted-by":"publisher","first-page":"1265797","DOI":"10.3389\/fimmu.2023.1265797","volume":"14","author":"N Vorasoot","year":"2023","unstructured":"Vorasoot N, Scharf M, Miske R, et al. CDR2 and CDR2L line blot performance in PCA-1\/anti-Yo paraneoplastic autoimmunity. Front Immunol. 2023;14:1265797. https:\/\/doi.org\/10.3389\/fimmu.2023.1265797.","journal-title":"Front Immunol"},{"issue":"5","key":"2047_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/ana.410280515","volume":"28","author":"K Sakai","year":"1990","unstructured":"Sakai K, Mitchell DJ, Tsukamoto T, Steinman L. Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration. Ann Neurol. 1990;28(5):692\u20138. https:\/\/doi.org\/10.1002\/ana.410280515.","journal-title":"Ann Neurol"},{"issue":"8","key":"2047_CR3","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1073\/pnas.88.8.3451","volume":"88","author":"H Fathallah-Shaykh","year":"1991","unstructured":"Fathallah-Shaykh H, Wolf S, Wong E, Posner JB, Furneaux HM. Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A. 1991;88(8):3451\u20134. https:\/\/doi.org\/10.1073\/pnas.88.8.3451.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2047_CR4","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/ana.25511","volume":"86","author":"T Kr\u00e5kenes","year":"2019","unstructured":"Kr\u00e5kenes T, Herdlev\u00e6r I, Raspotnig M, Haugen M, Schubert M, Vedeler CA. CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration. Ann Neurol. 2019;86(2):316\u201321. https:\/\/doi.org\/10.1002\/ana.25511.","journal-title":"Ann Neurol"},{"issue":"4","key":"2047_CR5","doi-asserted-by":"publisher","first-page":"e1014","DOI":"10.1212\/NXI.0000000000001014","volume":"8","author":"F Graus","year":"2021","unstructured":"Graus F, Vogrig A, Mu\u00f1iz-Castrillo S, et al. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. Neurol Neuroimmunol Neuroinflamm. 2021;8(4):e1014. https:\/\/doi.org\/10.1212\/NXI.0000000000001014.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"2047_CR6","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1007\/s12311-019-01045-1","volume":"18","author":"S Bhardwaj","year":"2019","unstructured":"Bhardwaj S, Khasani S, Benasher D, et al. Paraneoplastic Cerebellar Degeneration in Nasopharyngeal Carcinoma: a Unique Association. Cerebellum. 2019;18(6):1126\u20139. https:\/\/doi.org\/10.1007\/s12311-019-01045-1.","journal-title":"Cerebellum"},{"key":"2047_CR7","doi-asserted-by":"publisher","first-page":"1558867","DOI":"10.3389\/fimmu.2025.1558867","volume":"16","author":"C Yang","year":"2025","unstructured":"Yang C, Xu Y, Fan S. Case Report: Anti-Yo antibody mediated paraneoplastic cerebellar degeneration in a patient with squamous cell lung carcinoma. Front Immunol. 2025;16:1558867. https:\/\/doi.org\/10.3389\/fimmu.2025.1558867.","journal-title":"Front Immunol"},{"issue":"2","key":"2047_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0022-510X(01)00467-1","volume":"185","author":"B Megli\u010d","year":"2001","unstructured":"Megli\u010d B, Graus F, Grad A. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma. J Neurol Sci. 2001;185(2):135\u20138. https:\/\/doi.org\/10.1016\/S0022-510X(01)00467-1.","journal-title":"J Neurol Sci"},{"issue":"2","key":"2047_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/1531-8249(20010201)49:2<253::AID-ANA47>3.0.CO;2-3","volume":"49","author":"IJ Sutton","year":"2001","unstructured":"Sutton IJ, Fursdon Davis CJ, Esiri MM, Hughes S, Amyes ER, Vincent A. Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus. Ann Neurol. 2001;49(2):253\u20137. https:\/\/doi.org\/10.1002\/1531-8249(20010201)49:2%3C253::AID-ANA47%3E3.0.CO;2-3.","journal-title":"Ann Neurol"},{"issue":"5","key":"2047_CR10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000107782","volume":"24","author":"JD Debes","year":"2007","unstructured":"Debes JD, Lagarde SM, Hulsenboom E, et al. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of the gastroesophageal junction. Dig Surg. 2007;24(5):395\u20137. https:\/\/doi.org\/10.1159\/000107782.","journal-title":"Dig Surg"},{"issue":"2","key":"2047_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1017\/cjn.2016.400","volume":"44","author":"N Rosine","year":"2017","unstructured":"Rosine N, Chr\u00e9tien P, Adam C, et al. Expression of Yo Antigen in a Prostatic Adenocarcinoma. Can J Neurol Sci. 2017;44(2):221\u20133. https:\/\/doi.org\/10.1017\/cjn.2016.400.","journal-title":"Can J Neurol Sci"},{"issue":"4","key":"2047_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12311-009-0128-2","volume":"8","author":"Y Karmon","year":"2009","unstructured":"Karmon Y, Inbar E, Cordoba M, Gadoth N. Paraneoplastic cerebellar degeneration mimicking acute post-infectious cerebellitis. Cerebellum. 2009;8(4):441\u20134. https:\/\/doi.org\/10.1007\/s12311-009-0128-2.","journal-title":"Cerebellum"},{"issue":"4","key":"2047_CR13","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/1352458510389488","volume":"17","author":"R Gracien","year":"2011","unstructured":"Gracien R, Kordulla M, Ziemann U. Paraneoplastic cerebellar degeneration mimicking development of secondary progressive multiple sclerosis in a patient with relapsing-remitting multiple sclerosis. Mult Scler. 2011;17(4):498\u2013500. https:\/\/doi.org\/10.1177\/1352458510389488.","journal-title":"Mult Scler"},{"issue":"4","key":"2047_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.5692\/clinicalneurol.cn-000851","volume":"56","author":"S Nagao","year":"2016","unstructured":"Nagao S, Kondo T, Nakamura T, Nakagawa T, Matsumoto S. A case of human immunodeficiency virus infection with cerebellar ataxia that suggested by an association with autoimmunity. Rinsho Shinkeigaku. 2016;56(4):255\u20139. https:\/\/doi.org\/10.5692\/clinicalneurol.cn-000851.","journal-title":"Rinsho Shinkeigaku"},{"issue":"1","key":"2047_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76(1):9\u201316. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210571.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"2047_CR16","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s00262-017-2041-8","volume":"66","author":"M Raspotnig","year":"2017","unstructured":"Raspotnig M, Haugen M, Thorsteinsdottir M, et al. Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies. Cancer Immunol Immunother. 2017;66(11):1463\u201371. https:\/\/doi.org\/10.1007\/s00262-017-2041-8.","journal-title":"Cancer Immunol Immunother"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-02047-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-026-02047-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-02047-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:10:09Z","timestamp":1786165809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-026-02047-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":16,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2047"],"URL":"https:\/\/doi.org\/10.1007\/s12311-026-02047-6","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"9 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research was conducted ethically in accordance with the World Medical Association Declaration of Helsinki. The patient provided written informed consent for the publication of this paper including images. The study is exempt from ethical committee approval because this is a case report study and does not include experiments on animal and\/or human subjects.","order":1,"name":"Ethics","label":"Statement of ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work the authors used ChatGPT-5.5 in order to improve language and readability. After using this tool, the authors reviewed and edited the content as needed and they take full responsibility for the content of the publication.","order":3,"name":"Ethics","label":"Declaration of generative ai in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"98"}}